-
1 Comment
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. is currently in a long term downtrend where the price is trading 20.5% below its 200 day moving average.
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue sank by 4.9% to $12M since the same quarter in the previous year.
Its net income has increased by 137.8% to $4M since the same quarter in the previous year.
Finally, its free cash flow fell by 122.9% to $-2M since the same quarter in the previous year.
Based on the above factors, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. gets an overall score of 1/5.
| Industry | Biotechnology |
|---|---|
| Sector | Healthcare |
| ISIN | PLBMDLB00018 |
| CurrencyCode | PLN |
| Exchange | WAR |
| PE Ratio | 61.12 |
|---|---|
| Dividend Yield | 0.0% |
| Target Price | None |
| Market Cap | 399M |
| Beta | 1.35 |
BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A., a pharmaceutical company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50 and BCG 100 products for treating superficial (non-muscle invasive) bladder tumor; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topical control of severe bleeding; and Anti-Tuberculosis Vaccine BCG 10, a medication used in tuberculosis prevention. It also offers medical products comprising Ram blood for laboratory use; stonebrink medium for biovine Mycobacterium tuberculosis diagnostics; Löwenstein-Jensen medium with medicines for testing medicine susceptibility of Mycobacterium tuberculosis; Löwenstein-Jensen medium containing glycerolfor is used for identification of Mycobacterium tuberculosis; Ox Thrombin for in-vitro diagnostics and Lyophilisate; and rabbit plasma. In addition, the company provides reagents, such as horse serum, bovine serum, calf serum, trypsin, PBS fluid, hanks fluid, parker's fluid, Eagle 1959 medium, Rpmi 1640 medium, and Ogawa medium, as well as pseudo cholinesterase, Ox fibrinogen, and rabbit complements. BIOMED-LUBLIN Wytwórnia Surowic i Szczepionek S.A. was founded in 1944 and is based in Lublin, Poland.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BML.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2024
